These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 15385122

  • 1. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C.
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sparing fertility in young patients with endometrial cancer.
    Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A, Gonzalez-Martín A.
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [Abstract] [Full Text] [Related]

  • 4. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of leuprolide in advanced/recurrent endometrial cancer.
    Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K.
    Gynecol Oncol; 1997 Jan; 64(1):126-9. PubMed ID: 8995560
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY, Lee SH, Seong SJ, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH.
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D, Lindner T, Mrozek A, Kretzschmar A, Thuss-Patience PC, Dörken B, Reichardt P.
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
    Shirali E, Yarandi F, Eftekhar Z, Shojaei H, Khazaeipour Z.
    Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
    [Abstract] [Full Text] [Related]

  • 12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hormonal therapy for endometrial adenocarcinoma].
    Susumu N, Aoki D, Suzuki N, Nozawa S.
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.